Avidity Partners Management LP Bridge Bio Pharma, Inc. Transaction History
Avidity Partners Management LP
- $445 Million
- Q1 2025
A detailed history of Avidity Partners Management LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 75,000 shares of BBIO stock, worth $3.09 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
75,000Holding current value
$3.09 Million% of portfolio
0.58%Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$907 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$792 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$613 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$512 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$295 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.1B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...